Company intelligence

IVVD

Invivyd, Inc. · NASDAQ · Healthcare

Price$0.93+2.29% · +$0.02

Market cap275.22MEquity value

P / E-3.0Trailing ratio

Volume3.46MLatest session

Market data

IVVD price chart

TradingView

Related signals

1 min delayed

Browse public IVVD signals with their source context and measured market impact. Open any signal for its permanent analysis page.

IVVDApr 9, 2026+18.52% since signal

Invivyd Reaches Key Milestone for VYD2311 Trial; Data Update Expected 2026

Invivyd achieved a critical milestone in its Phase 3 DECLARATION trial for VYD2311, expanding the study size to enhance clinical results. Topline data is now pushed to Q3 2026, while alignment with the FDA on pediatric development and progress on measles treatment opens additional market opportunities.

View signal analysis

Research